Dna Group (T.R.) Ltd DNA.TA
DNA.TA
Dna Group (T.R.) Ltd GFC-M.TA
G.F.C Green Fields Capital Ltd. KDST.TA
Kadimastem Ltd PLUR.TA
Pluri Inc. REKA.TA
Rekah Pharmaceutical Industry Ltd. ENLV.TA
Enlivex Therapeutics Ltd. GEFR.TA
Geffen Residence & Renewal Ltd BLRX.TA
BioLineRx Ltd. CBI.TA
Clal Biotechnology Industries Ltd. CANF.TA
Can-Fite BioPharma Ltd.
Dna Group (T.R.) Ltd GFC-M.TA
G.F.C Green Fields Capital Ltd. KDST.TA
Kadimastem Ltd PLUR.TA
Pluri Inc. REKA.TA
Rekah Pharmaceutical Industry Ltd. ENLV.TA
Enlivex Therapeutics Ltd. GEFR.TA
Geffen Residence & Renewal Ltd BLRX.TA
BioLineRx Ltd. CBI.TA
Clal Biotechnology Industries Ltd. CANF.TA
Can-Fite BioPharma Ltd.
Performance
| Periode | DNA.TA | GFC-M.TA | KDST.TA | PLUR.TA | REKA.TA | ENLV.TA | GEFR.TA | BLRX.TA | CBI.TA | CANF.TA |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 18.20 % | 9.17 % | 35.47 % | 0.63 % | 2.75 % | 13.46 % | 42.33 % | 37.50 % | 5.57 % | -41.18 % |
| YTD | 31.61 % | 13.91 % | 157.41 % | -8.56 % | -9.81 % | -9.26 % | 23.75 % | -65.63 % | 3.15 % | -47.37 % |
| 1Y | 37.36 % | 5.56 % | 299.37 % | -25.14 % | -13.66 % | -32.23 % | 27.88 % | -82.68 % | -10.22 % | -67.74 % |
| 3Y | 6.13 % | 36.17 % | 164.26 % | -30.21 % | -29.66 % | -75.00 % | 0.84 % | -89.67 % | -52.51 % | -89.58 % |
| 5Y | 61.92 % | 17.70 % | 23.36 % | -95.22 % | -55.74 % | -91.91 % | -25.77 % | -94.07 % | -80.58 % | -95.31 % |
| 10Y | -54.21 % | 67.95 % | -91.97 % | -97.34 % | -33.61 % | -96.28 % | -59.81 % | -99.62 % | -86.75 % | -99.87 % |
| From the beginning | -95.87 % | 184.16 % | -91.09 % | -96.84 % | 181.18 % | -96.28 % | -91.02 % | -99.96 % | -96.48 % | -99.97 % |